BioCryst Pharma Stock Price (NASDAQ:BCRX)

Add to My Stocks
$5.04 $0.16 (3.08%) BCRX stock closing price Jul 25, 2017 (Closing)
Prev Close* : $5.20
Market Cap:
$418.19M
Day Low: $5.03
52 Week Low: $2.98
Open: $5.23
Volume: 830061
Day High: $5.23
52 Week High: $9.25
Dividend:
N/A

Latest Stock Market News

Latest Articles

BioCryst Pharma News - From Partners

BioCryst Reports First Quarter 2017 Financial Results   by Globe Newswire on May 04, 2017

BCRX Stockcharts

View BCRX PE ratio, PS ratio stocks charts and compare with peers.
BCRX Chart
Note: Compare BioCryst Pharma stock price history with the index and industry peers.

BioCryst Pharma Valuation

PS ratio (
price to sales ratio
)
12.23
PB ratio (
price to book ratio
)
22.22

BioCryst Pharma Financial Ratios

Asset Turnover
0.34
Receivables Turnover
4.57
Debt to Equity
1.4

BCRX Industry Peers

Company Price Change (%)
Sucampo Pharma (SCMP)11.050.05 (0.45%)
Chemocentryx (CCXI)10.090.16 (1.56%)
Gilead Sciences (GILD)73.740.65 (0.87%)
Sarepta Therapeutics (SRPT)42.541.41 (3.21%)
Aviragen Therapeutics (AVIR)0.560 (0%)
Achillion Pharma (ACHN)4.220.05 (1.17%)
Nanoviricides (NNVC)1.480.03 (2.07%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Redhill Biopharma (RDHL)10.50.74 (7.58%)
AcelRx Pharma (ACRX)3.80.15 (4.11%)
Recro Pharma (REPH)7.840.29 (3.84%)
Genocea Biosciences (GNCA)60.17 (2.92%)
Depomed (DEPO)10.790.28 (2.66%)
Aratana Therapeutics (PETX)7.250.12 (1.68%)
Shire (SHPG)166.112.47 (1.51%)
Top gainers from Medical-Drugs industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Pacira Pharma (PCRX)42.656.05 (12.42%)
Achaogen (AKAO)19.92.05 (9.34%)
Ionis Pharma (IONS)54.714.85 (8.14%)
Tetraphase Pharmaceuticals (TTPH)6.90.4 (5.48%)
GlycoMimetics (GLYC)11.660.44 (3.64%)
ImmunoGen (IMGN)6.120.22 (3.47%)
Rigel Pharma (RIGL)2.520.09 (3.45%)
Top losers from Medical-Drugs industry
* As of Jul 26, 2017

BioCryst Pharmaceuticals, Inc. Stock News - Partner Headlines

BioCryst Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues26.35M48.25M13.6M17.33M26.29M
Net Income-55.14M-43.01M-45.18M-30.1M-39.08M
Total Operating Expense72.65M86.32M59.37M48.04M60.17M
view BioCryst Pharmaceuticals, Inc. income statement
balance sheet20162015201420132012
Total Assets89.84M124.55M136.87M48.86M57.43M
Total Liabilities88.26M76.83M61.23M49.99M57.89M
Shareholders Equity1.57M47.72M75.63M-1.12M-0.45M
view BioCryst Pharmaceuticals, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-7.55M19.01M1.3M3.8M-4.29M
Net Cash From (Used By) Operating Activities-53.43M-13.11M-38.55M-26.53M-37.39M
Increase (Decrease) In Prop Plant And Equipment-5.27M-5.12M-0.1M0.02M-0.11M
view BioCryst Pharmaceuticals, Inc. cashflow statement

BioCryst Pharma Stock Message Board

BioCryst Pharma stock lost -3.08 %, and the last close price as of 25 Jul, 2017 is 5.04 for BCRX stock. BioCryst Pharma market capitalization is 418.19M and it represents the total market value of BCRX stock. A value investor must look at the fundamentals of a stock, and perform BioCryst Pharma valuation, even though in the short-term sentiment and current breaking news might affect BioCryst Pharma stock price.

For recognizing and analyzing the real performance of BioCryst Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 830061 shares were traded with a closing stock price of 5.04 as of 25 Jul, 2017, as can be seen from BioCryst Pharma stock quote. One can view BioCryst Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. BioCryst Pharma does not pay dividends. BioCryst Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.